Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 10/20 | 0.97 |
| ▸ | BLM | P54132 | 2/20 | 0.97 |
| ▸ | HBB | P68871 | 2/20 | 0.97 |
| ▸ | USP2 | O75604 | 1/20 | 0.97 |
| ▸ | TSHR | P16473 | 1/20 | 0.97 |
| ▸ | EDNRA | P25101 | 1/20 | 0.97 |
| ▸ | HTR2A | P28223 | 1/20 | 0.97 |
| ▸ | RECQL | P46063 | 1/20 | 0.97 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.97 |
| ▸ | HPRT1 | P00492 | 3/20 | 0.74 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.68 |
| ▸ | VCP | P55072 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.68 |
| ▸ | POLG | P54098 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acyclovir SCHEMBL29165535 | 0.99 | PNP (0.95) | PNPBLMHBBUSP2TSHR | |
| Acyclovir SCHEMBL8068438 | 0.99 | PNP (0.95) | PNPBLMHBBUSP2TSHR | |
| Acyclovir SCHEMBL2269160 | 0.99 | PNP (1.00) | PNPBLMHBBUSP2TSHR | |
| Acyclovir SCHEMBL3664893 | 0.99 | PNP (1.00) | PNPBLMHBBUSP2TSHR | |
| Acyclovir SCHEMBL3175 | 0.99 | PNP (1.00) | PNPBLMHBBUSP2TSHR | |
| Acyclovir SCHEMBL6239258 | 0.97 | PNP (0.97) | PNPBLMHBBUSP2TSHR | |
| Acyclovir SCHEMBL16060281 | 0.97 | PNP (0.97) | PNPBLMHBBUSP2TSHR | |
| Acyclovir SCHEMBL19031784 | 0.97 | PNP (0.97) | PNPBLMHBBUSP2TSHR | |
| Acyclovir SCHEMBL16061083 | 0.97 | PNP (0.97) | PNPBLMHBBUSP2TSHR | |
| Acyclovir SCHEMBL29531632 | 0.97 | PNP (0.97) | PNPBLMHBBUSP2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2028 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026043843-A1 | TETRAHYDROPYRIMIDINE (THP) IONIZABLE LIPIDS FOR EFFICIENT MRNA DELIVERY | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) | 2026-02-26 | — | — | WO | claimed |
| WO-2024215771-A1 | SUBSTITUTED PHENYL ETHYNYL PYRIMIDINES AS POTENT INHIBITORS OF ALPHAVIRUSES | SOUTHERN RESEARCH INSTITUTE (US) | 2024-10-17 | — | — | WO | claimed |
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| CN-117860743-A | Application of sirolimus in preparation of specific binding agent of coronavirus spike protein receptor binding domain | 五邑大学 | 2024-04-12 | — | — | CN | claimed |
| CN-115919823-B | Application of benserazide hydrochloride in preparing medicament for treating diseases caused by respiratory syncytial virus | 浙江艾特为生物科技有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-117677631-A | Novel compositions and methods for treating coronavirus infections | 昆士兰医学研究所理事会 | 2024-03-08 | — | — | CN | claimed |
| EP-4326757-A1 | NOVEL COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS | The Council of the Queensland Institute of Medical Research (AU) | 2024-02-28 | — | — | EP | claimed |
| EP-4262812-A1 | 6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS | Southern Research Institute (US) | 2023-10-25 | — | — | EP | claimed |
| WO-2023122212-A2 | SUBSTITUTED PHENYL ETHYNYL PYRIDINE CARBOXAMIDES AS POTENT INHIBITORS OF SARS VIRUS | SOUTHERN RESEARCH INSTITUTE (US) | 2023-06-29 | — | — | WO | claimed |
| CN-115916175-A | Novel 2-pyrimidinone analogs as potent antiviral agents against alphaviruses | 南方研究院 | 2023-04-04 | — | — | CN | claimed |
| WO-2000024386-A1 | METHOD OF MAKING PRESSURE SENSITIVE ADHESIVE MATRIX PATCHES CONTAINING HYDROPHILIC SALTS OF DRUGS | THERATECH, INC. (US) | 2000-05-04 | — | — | WO | claimed |
| WO-1999063970-A1 | DELAVIRDINE TABLET FORMULATION | PHARMACIA & UPJOHN COMPANY (US) | 1999-12-16 | — | — | WO | claimed |
| US-5985317-A | POLYISOBUTYLENE; BACKING IMPERMEABLE TO DICLOFENAC SODIUM | THERATECH, INC. (US) | 1999-11-16 | — | — | US | claimed |
| EP-0952799-A1 | PRESSURE SENSITIVE ADHESIVE MATRIX PATCHES FOR TRANSDERMAL DELIVERY OF SALTS OF PHARMACEUTICAL AGENTS | THERATECH, INC. (US) | 1999-11-03 | — | — | EP | claimed |
| WO-1998031370-A1 | READY-TO-USE SOLUTION DRUG PRODUCT AND CLOSURE SYSTEM | MERIDIAN MEDICAL TECHNOLOGIES, INC. (US) | 1998-07-23 | — | — | WO | claimed |
| WO-1998009591-A1 | PRESSURE SENSITIVE ADHESIVE MATRIX PATCHES FOR TRANSDERMAL DELIVERY OF SALTS OF PHARMACEUTICAL AGENTS | THERATECH, INC. (US) | 1998-03-12 | — | — | WO | claimed |
| US-5357636-A | Flexible protective medical gloves and methods for their use | DRESDNER JR KARL P (US) | 1994-10-25 | — | — | US | claimed |
| EP-0544878-A1 | ASIALOGLYCOPROTEIN-CONJUGATED MEDICINAL AGENT | COREA GREEN CROSS CORPORATION (KR) | 1993-06-09 | — | — | EP | claimed |
| CN-1068744-A | The medicament of Asialoglycoprotein-conjugated medicinal | LIVER RESEARCH FOUNDATION OF K (KR) | 1993-02-10 | — | — | CN | claimed |
| WO-1992022310-A1 | ASIALOGLYCOPROTEIN-CONJUGATED MEDICINAL AGENT | LIVER RESEARCH FOUNDATION OF KOREA (KR) | 1992-12-23 | — | — | WO | claimed |